Rausch, Valentina
Sala, Valentina
Penna, Fabio
Porporato, Paolo Ettore http://orcid.org/0000-0001-8519-1552
Ghigo, Alessandra http://orcid.org/0000-0002-1193-5296
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (23951)
Ministero della Salute (GR-2013-02355449, RF-2013-02354892)
Fondazione Cariplo (GR 2017-0800)
Article History
Received: 22 June 2020
Revised: 26 October 2020
Accepted: 2 November 2020
First Online: 8 January 2021
Conflict of interest
: A.G. is co-founder and Board Member of Kither Biotech, a company focused on the development of PI3K inhibitors for airway diseases not in conflict with statements in this article. The other authors have no competing financial interest to disclose in relation to the work described. Work is supported by AIRC (P.E.P.: MFAG 21564; VR:23951), Ricerca Finalizzata (A.G.: RF-2013-02354892; V.S.: GR-2013-02355449), Fondazione Cariplo (V.S.: GR 2017-0800).